Overview

Gender

male

Investor Type

Investment Partner

Patrick Enright is the Board Member at Esperion Therapeutics.He has served as a Member Of Board Of Directors since April 2013.He is also the Managing Director, Longitude Capital Management Co., LLC. Patrick is a founder of Longitude Capital Management Co., LLC, a venture capital firm focused on investments in biotechnology, and has served as its Managing Director since 2007.

From 2002 through 2006, Patrick was a Managing Director of Pequot Ventures where he co-led the life sciences investment practice. Prior to Pequot, Patrick was a Managing Member responsible for the Delta Opportunity Fund, where he invested in privately held and publicly traded biotechnology companies.

Patrick is a director of a number of companies including,Corcept Therapeutics, Inc. (NASDAQ: CORT),Jazz Pharmaceuticals plc (NASDAQ: JAZZ).Patrick earned an M.B.A. from the Wharton School of Business at the University of Pennsylvania.B.S. in Biological Sciences from Stanford University.